Feb 2, 2011 | PR-inside.com
Just Released: "Synthetech, Inc. (NZYM) - Financial and Strategic Analysis Review"
Financial and Strategic Analysis Review Summary Synthetech, Inc. is a publicly held pharmaceutical company specializing in organic synthesis, bio catalysis and chiral technologies.